What drug information should the consumer have? - A consumer perspective

Prognosis of uveal melanoma based on race in 8100 patients: The 2015 Doyne Lecture.

Eye (London, England)·2015

Open transnasal approach to the midline skull base.

The Journal of craniofacial surgery·1996

Mandibular distraction osteogenesis: effects on articulation and velopharyngeal function.

The Journal of craniofacial surgery·1996

Prognostic factors in acute pulmonary edema.

Archives of internal medicine·1986

Benign cysts of the parotid gland.

Journal of surgical oncology·1984

Comparative effects of abrupt withdrawal of propranolol and verapamil in angina pectoris.

The American journal of cardiology·1982

A clinical pharmacologic perspective on the detection and assessment of adverse drug reactions.

Drug information journal·2014

Effective Strategies for Maintaining Research Participation in Clinical Trials.

Drug information journal·2013

Evaluation of Data Entry Errors and Data Changes to an Electronic Data Capture Clinical Trial Database.

Drug information journal·2013

A Patient Focused Solution for Enrolling Clinical Trials in Rare and Selective Cancer Indications: A Landscape of Haystacks and Needles.

Drug information journal·2013

Relative Efficiency of Unequal Versus Equal Cluster Sizes for the Nonparametric Weighted Sign Test Estimators in Clustered Binary Data.

Drug information journal·2013

Testing in a Prespecified Subgroup and the Intent-to-Treat Population.

Drug information journal·2012

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Cureus·2026

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Frontiers in endocrinology·2026

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Canadian journal of kidney health and disease·2026

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Frontiers in pharmacology·2026

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Frontiers in molecular neuroscience·2026

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Therapeutic advances in neurological disorders·2026

Related Experiment Videos

What drug information should the consumer have? - A consumer perspective

Related Concept Videos

Prognosis of uveal melanoma based on race in 8100 patients: The 2015 Doyne Lecture.

Open transnasal approach to the midline skull base.

Mandibular distraction osteogenesis: effects on articulation and velopharyngeal function.

Prognostic factors in acute pulmonary edema.

Benign cysts of the parotid gland.

Comparative effects of abrupt withdrawal of propranolol and verapamil in angina pectoris.

A clinical pharmacologic perspective on the detection and assessment of adverse drug reactions.

Effective Strategies for Maintaining Research Participation in Clinical Trials.

Evaluation of Data Entry Errors and Data Changes to an Electronic Data Capture Clinical Trial Database.

A Patient Focused Solution for Enrolling Clinical Trials in Rare and Selective Cancer Indications: A Landscape of Haystacks and Needles.

Relative Efficiency of Unequal Versus Equal Cluster Sizes for the Nonparametric Weighted Sign Test Estimators in Clustered Binary Data.

Testing in a Prespecified Subgroup and the Intent-to-Treat Population.

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Related Experiment Videos

What drug information should the consumer have? - A consumer perspective

Related Concept Videos

Related Articles